Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer
about
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical pharmacology of an at ...... one-refractory prostate cancer
@ast
Clinical pharmacology of an at ...... one-refractory prostate cancer
@en
type
label
Clinical pharmacology of an at ...... one-refractory prostate cancer
@ast
Clinical pharmacology of an at ...... one-refractory prostate cancer
@en
prefLabel
Clinical pharmacology of an at ...... one-refractory prostate cancer
@ast
Clinical pharmacology of an at ...... one-refractory prostate cancer
@en
P2093
P2860
P921
P1476
Clinical pharmacology of an at ...... one-refractory prostate cancer
@en
P2093
Andrew J. Armstrong
Cody J. Peer
Daniel J. George
Gerald Hobbs
Herbert Hurwitz
Islam R. Younis
Jing Jie Yu
Kristina Bacon
Patricia Creel
Terence J. McManus
P2860
P2880
P2888
P304
P356
10.1007/S00280-014-2432-X
P577
2014-03-12T00:00:00Z
P6179
1006894164